Helicobacter pylori-induced gastric inflammation and gastric cancer

Cancer Letters

Volumn 345, Issue 2, 2014, Pages 196-202

  Wang, Fei ^a   Meng, Wenbo ^b   Wang, Bingyuan ^c   Qiao, Liang ^d  

^a FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

^b LANZHOU UNIVERSITY   (China)

^c CHINA MEDICAL UNIVERSITY   (China)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

CagA; Epigenetic changes; Gastric cancer; Helicobacter pylori; VacA

Indexed keywords

CAGA PROTEIN; DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN P53; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; VACUOLATING TOXIN; VIRULENCE FACTOR;

BACTERIAL METABOLISM; CANCER STEM CELL; DISEASE ASSOCIATION; DNA DAMAGE; EPIGENETICS; GASTRITIS; GENOTYPE ENVIRONMENT INTERACTION; HELICOBACTER INFECTION; HOST PATHOGEN INTERACTION; HUMAN; MARGINAL ZONE LYMPHOMA; NONHUMAN; OXIDATIVE STRESS; PATHOGENICITY ISLAND; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHORT SURVEY; SIGNAL TRANSDUCTION; STOMACH CANCER; STOMACH CARCINOGENESIS; STOMACH MUCOSA;

BACTERIA (MICROORGANISMS); HELICOBACTER PYLORI;

CAGA; EPIGENETIC CHANGES; GASTRIC CANCER; HELICOBACTER PYLORI; VACA;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; GASTRIC MUCOSA; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNITY, MUCOSAL; INFLAMMATION MEDIATORS; RISK FACTORS; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS; VIRULENCE FACTORS;

EID: 84896721521     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2013.08.016     Document Type: Review

References (75)

1. Linz B., Balloux F., Moodley Y., Manica A., Liu H., Roumagnac P., Falush D., Stamer C., Prugnolle F., van der Merwe S.W., Yamaoka Y., Graham D.Y., Perez-Trallero E., Wadstrom T., Suerbaum S., Achtman M. An African origin for the intimate association between humans and Helicobacter pylori. Nature 2007, 445:915-918.
2. Marshall B.J., Warren J.R. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984, 1:1311-1315.
3. Parkin D.M., Bray F., Ferlay J., Pisani P. Global cancer statistics 2002. CA Cancer J. Clin. 2005, 55:74-108.
4. Wang A.Y., Peura D.A. The prevalence and incidence of Helicobacter pylori-associated peptic ulcer disease and upper gastrointestinal bleeding throughout the world. Gastrointest. Endosc. Clin. N. Am. 2011, 21:613-635.
5. Carter F.P., Frankson T., Pintard J., Edgecombe B. Seroprevalence of Helicobacter pylori infection in adults in the Bahamas. West Indian Med. J. 2011, 60:662-665.
6. Warren J.R. Gastric pathology associated with Helicobacter pylori. Gastroenterol. Clin. North Am. 2000, 29:705-751.
7. Noto J.M., Peek R.M. Helicobacter pylori: an overview. Methods Mol. Biol. 2012, 921:7-10.
8. Elzouki A.-N.Y., Buhjab S.I., Alkialani A., Habel S., Sasco A.J. Gastric cancer and Helicobacter pylori infection in the Eastern Libya: a descriptive epidemiological study. Arab J. Gastroenterol. 2012, 13:85-88.
9. Kamangar F., Dawsey S.M., Blaser M.J., Perez-Perez G.I., Pietinen P., Newschaffer C.J., Abnet C.C., Albanes D., Virtamo J., Taylor P.R. Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity. J. Natl. Cancer Inst. 2006, 98:1445-1445.
10. Kamada T., Kurose H., Yamanaka Y., Manabe N., Kusunoki H., Shiotani A., Inoue K., Hata J., Matsumoto H., Akiyama T., Hirai T., Sadahira Y., Haruma K. Relationship between gastroesophageal junction adenocarcinoma and Helicobacter pylori infection in Japan. Digestion 2012, 85:256-260.
11. Asenjo L.M., Gisbert J.P. Prevalence of Helicobacter pylori infection in gastric MALT lymphoma: a systematic review. Rev. Esp. Enferm. Dig. 2007, 99:398-404.
12. Kusters J.G., van Vliet A.H.M., Kuipers E.J. Pathogenesis of Helicobacter pylori infection. Clin. Microbiol. Rev. 2006, 19:449-490.
13. Zullo A., Hassan C., Cristofari F., Andriani A., De Francesco V., Ierardi E., Tomao S., Stolte M., Morini S., Vaira D. Effects of Helicobacter pylori eradication on early stage gastric mucosa-associated lymphoid tissue lymphoma. Clin. Gastroenterol. Hepatol. 2010, 8:105-110.
14. Wündisch T., Dieckhoff P., Greene B., Thiede C., Wilhelm C., Stolte M., Neubauer A. Second cancers and residual disease in patients treated for gastric mucosa-associated lymphoid tissue lymphoma by Helicobacter pylori eradication and followed for 10years. Gastroenterology 2012, 143:936-942.
15. Muller A. Multistep activation of the Helicobacter pylori effector CagA. J. Clin. Invest. 2012, 122:1192-1195.
16. Van Nhieu G.T., Jiménez-Soto L.F., Kutter S., Sewald X., Ertl C., Weiss E., Kapp U., Rohde M., Pirch T., Jung K., Retta S.F., Terradot L., Fischer W., Haas R. Helicobacter pylori type iv secretion apparatus exploits β1 integrin in a novel RGD-independent manner. PLoS Pathog. 2009, 5:e1000684.
17. Xu X., Liu Z., Fang M., Yu H., Liang X., Li X., Liu X., Chen C., Jia J. Helicobacter pylori CagA induces ornithine decarboxylase upregulation via Src/MEK/ERK/c-Myc pathway: implication for progression of gastric diseases. Exp. Biol. Med. 2012, 237:435-441.
18. Mueller D., Tegtmeyer N., Brandt S., Yamaoka Y., De Poire E., Sgouras D., Wessler S., Torres J., Smolka A., Backert S. C-Src and c-Abl kinases control hierarchic phosphorylation and function of the CagA effector protein in Western and East Asian Helicobacter pylori strains. J. Clin. Invest. 2012, 122:1553-1566.
19. Hold G.L., Lee K.S., Kalantzis A., Jackson C.B., O'Connor L., Murata-Kamiya N., Hatakeyama M., Judd L.M., Giraud A.S., Menheniott T.R. Helicobacter pylori CagA triggers expression of the bactericidal lectin REG3γ via gastric STAT3 activation. PLoS One 2012, 7:e30786.
20. Mimuro H., Suzuki T., Tanaka J., Asahi M., Haas R., Sasakawa C. Grb2 is a key mediator of Helicobacter pylori CagA protein activities. Mol. Cell. 2002, 10:745-755.
21. Murata-Kamiya N., Kurashima Y., Teishikata Y., Yamahashi Y., Saito Y., Higashi H., Aburatani H., Akiyama T., Peek R.M., Azuma T., Hatakeyama M. Helicobacter pylori CagA interacts with E-cadherin and deregulates the β-catenin signal that promotes intestinal transdifferentiation in gastric epithelial cells. Oncogene 2007, 26:4617-4626.
22. Wroblewski L.E., Peek R.M., Wilson K.T. Helicobacter pylori and gastric cancer: factors that modulate disease risk. Clin. Microbiol Rev. 2010, 23:713-739.
23. Kaplan-Turkoz B., Jimenez-Soto L.F., Dian C., Ertl C., Remaut H., Louche A., Tosi T., Haas R., Terradot L. Structural insights into Helicobacter pylori oncoprotein CagA interaction with beta1 integrin. Proc. Natl. Acad. Sci. USA 2012, 109:14640-14645.
24. Buti L., Spooner E., Van der Veen A.G., Rappuoli R., Covacci A., Ploegh H.L. Helicobacter pylori cytotoxin-associated gene A (CagA) subverts the apoptosis-stimulating protein of p53 (ASPP2) tumor suppressor pathway of the host. Proc. Natl. Acad. Sci. USA 2011, 108:9238-9243.
25. Tsang Y.H., Lamb A., Romero-Gallo J., Huang B., Ito K., Peek R.M., Ito Y., Chen L.F. Helicobacter pylori CagA targets gastric tumor suppressor RUNX3 for proteasome-mediated degradation. Oncogene 2010, 29:5643-5650.
26. Lamb A., Yang X.-D., Tsang Y.-H.N., Li J.-D., Higashi H., Hatakeyama M., Peek R.M., Blanke S.R., Chen L.-F. Helicobacter pylori CagA activates NF-κB by targeting TAK1 for TRAF6-mediated Lys 63 ubiquitination. EMBO Rep. 2009, 10:1242-1249.
27. Boquet P., Ricci V. Intoxication strategy of Helicobacter pylori VacA toxin. Trends Microbiol. 2012, 20:165-174.
28. Rassow J., Meinecke M. Helicobacter pylori VacA: a new perspective on an invasive chloride channel. Microbes Infect. 2012, 14:1026-1033.
29. Jain P., Luo Z.Q., Blanke S.R. Helicobacter pylori vacuolating cytotoxin A (VacA) engages the mitochondrial fission machinery to induce host cell death. Proc. Natl. Acad. Sci. USA 2011, 108:16032-16037.
30. Palframan S.L., Kwok T., Gabriel K. Vacuolating cytotoxin A (VacA), a key toxin for Helicobacter pylori pathogenesis. Front. Cell Infect. Microbiol. 2012, 2:92.
31. Raju D., Hussey S., Ang M., Terebiznik M.R., Sibony M., Galindo-Mata E., Gupta V., Blanke S.R., Delgado A., Romero-Gallo J., Ramjeet M.S., Mascarenhas H., Peek R.M., Correa P., Streutker C., Hold G., Kunstmann E., Yoshimori T., Silverberg M.S., Girardin S.E., Philpott D.J., El Omar E., Jones N.L. Vacuolating Cytotoxin and Variants in Atg16L1 that disrupt autophagy promote Helicobacter pylori infection in humans. Gastroenterology 2012, 142:1160-1171.
32. Lamb A., Chen L.-F. Role of the Helicobacter pylori-induced inflammatory response in the development of gastric cancer. J. Cell Biochem. 2013, 114:491-497.
33. Brandt S. NF-B activation and potentiation of proinflammatory responses by the Helicobacter pylori CagA protein. Proc. Natl. Acad. Sci. USA 2005, 102:9300-9305.
34. Hayashi T., Senda M., Morohashi H., Higashi H., Horio M., Kashiba Y., Nagase L., Sasaya D., Shimizu T., Venugopalan N., Kumeta H., Noda Nobuo N., Inagaki F., Senda T., Hatakeyama M. Tertiary structure-function analysis reveals the pathogenic signaling potentiation mechanism of Helicobacter pylori oncogenic effector CagA. Cell Host Microbe 2012, 12:20-33.
35. Lamb A., Chen L.F. The many roads traveled by Helicobacter pylori to NFkappaB activation. Gut Microbes 2010, 1:109-113.
36. Takeshima E., Tomimori K., Kawakami H., Ishikawa C., Sawada S., Tomita M., Senba M., Kinjo F., Mimuro H., Sasakawa C., Fujita J., Mori N. NF-κB activation by Helicobacter pylori requires Akt-mediated phosphorylation of p65. BMC Microbiol. 2009, 9:36.
37. Ohmae T., Hirata Y., Maeda S., Shibata W., Yanai A., Ogura K., Yoshida H., Kawabe T., Omata M. Helicobacter pylori activates NF-kappaB via the alternative pathway in B lymphocytes. J. Immunol. 2005, 175:7162-7169.
38. Sun S.C. Non-canonical NF-kappaB signaling pathway. Cell Res. 2011, 21:71-85.
39. Hoffmann W. Stem cells, self-renewal and cancer of the gastric epithelium. Curr. Med. Chem. 2012, 19:5975-5983.
40. Yasui W., Sentani K., Sakamoto N., Anami K., Naito Y., Oue N. Molecular pathology of gastric cancer: research and practice. Pathol. Res. Pract. 2011, 207:608-612.
41. Xu G., Shen J., Ou Yang X., Sasahara M., Su X. Cancer stem cells: the 'heartbeat' of gastric cancer. J. Gastroenterol. 2012, 7:781-797.
42. Ferrand J., Lehours P., Schmid-Alliana A., Megraud F., Varon C. Helicobacter pylori infection of gastrointestinal epithelial cells in vitro induces mesenchymal stem cell migration through an NF-kappaB-dependent pathway. PLoS One 2011, 6:e29007.
43. Varon C., Dubus P., Mazurier F., Asencio C., Chambonnier L., Ferrand J., Giese A., Senant-Dugot N., Carlotti M., Mégraud F. Helicobacter pylori infection recruits bone marrow-derived cells that participate in gastric preneoplasia in mice. Gastroenterology 2012, 142:281-291.
44. Handa O., Naito Y., Yoshikawa T. Redox biology and gastric carcinogenesis: the role of Helicobacter pylori. Redox Rep. 2011, 16:1-7.
45. Wei J., Nagy T.A., Vilgelm A., Zaika E., Ogden S.R., Romero-Gallo J., Piazuelo M.B., Correa P., Washington M.K., El-Rifai W., Peek R.M., Zaika A. Regulation of p53 tumor suppressor by Helicobacter pylori in gastric epithelial cells. Gastroenterology 2010, 139:1333-1343.
46. Tsugawa H., Suzuki H., Saya H., Hatakeyama M., Hirayama T., Hirata K., Nagano O., Matsuzaki J., Hibi T. Reactive oxygen species-induced autophagic degradation of Helicobacter pylori CagA is specifically suppressed in cancer stem-like cells. Cell Host Microbe. 2012, 12:764-777.
47. Chaturvedi R., Sablet T., Coburn L.A., Gobert A.P., Wilson K.T. Arginine and polyamines in Helicobacter pylori-induced immune dysregulation and gastric carcinogenesis. Amino Acids 2011, 42:627-640.
48. Chaturvedi R., Asim M., Romero-Gallo J., Barry D.P., Hoge S., de Sablet T., Delgado A.G., Wroblewski L.E., Piazuelo M.B., Yan F., Israel D.A., Casero R.A., Correa P., Gobert A.P., Polk D.B., Peek R.M., Wilson K.T. Spermine oxidase mediates the gastric cancer risk associated with Helicobacter pylori CagA. Gastroenterology 2011, 141:1696-1708.
49. Wei J., Zaika E., Zaika A. P53 family: role of protein isoforms in human cancer. J. Nucleic Acids 2012, 2012:687359.
50. Levine A.J. The common mechanisms of transformation by the small DNA tumor viruses: the inactivation of tumor suppressor gene products: p53. Virology 2009, 384:285-293.
51. Xu H., Chaturvedi R., Cheng Y., Bussiere F.I., Asim M., Yao M.D., Potosky D., Meltzer S.J., Rhee J.G., Kim S.S., Moss S.F., Hacker A., Wang Y., Casero R.A., Wilson K.T. Spermine oxidation induced by Helicobacter pylori results in apoptosis and DNA damage: implications for gastric carcinogenesis. Cancer Res. 2004, 64:8521-8525.
52. Tabassam F.H., Graham D.Y., Yamaoka Y. Helicobacter pylori activate epidermal growth factor receptor- and phosphatidylinositol 3-OH kinase-dependent Akt and glycogen synthase kinase 3β phosphorylation. Cell Microbiol. 2009, 11:70-82.
53. Nakajima N., Ito Y., Yokoyama K., Uno A., Kinukawa N., Nemoto N., Moriyama M. The expression of Murine Double Minute 2 (MDM2) on Helicobacter pylori-infected intestinal metaplasia and gastric cancer. J. Clin. Biochem. Nutr. 2009, 44:196-202.
54. Fujita K., Mondal A.M., Horikawa I., Nguyen G.H., Kumamoto K., Sohn J.J., Bowman E.D., Mathe E.A., Schetter A.J., Pine S.R., Ji H., Vojtesek B., Bourdon J.-C., Lane D.P., Harris C.C. P53 isoforms δ133p53 and p53β are endogenous regulators of replicative cellular senescence. Nat. Cell Biol. 2009, 11:1135-1142.
55. Wei J., Noto J., Zaika E., Romero-Gallo J., Correa P., El-Rifai W., Peek R.M., Zaika A. PNAS Plus: pathogenic bacterium Helicobacter pylori alters the expression profile of p53 protein isoforms and p53 response to cellular stresses. Proc. Natl. Acad. Sci. USA 2012, 109:E2543-E2550.
56. Ushijima T., Asada K. Aberrant DNA methylation in contrast with mutations. Cancer Sci. 2010, 101:300-305.
57. Zhao C., Bu X. Promoter methylation of tumor-related genes in gastric carcinogenesis. Histol. Histopathol. 2012, 27:1271-1282.
58. Sepulveda A.R., Yao Y., Yan W., Park D.I., Kim J.J., Gooding W., Abudayyeh S., Graham D.Y. CpG methylation and reduced expression of O6-methylguanine DNA methyltransferase is associated with Helicobacter pylori infection. Gastroenterology 2010, 138:1836-1844.
59. Liu J.-B. CpG island methylator phenotype and Helicobacter pylori infection associated with gastric cancer. World J. Gastroenterol. 2012, 18:5129-5134.
60. Cheng A.S.L., Li M.S., Kang W., Cheng V.Y., Chou J.L., Lau S.S., Go M.Y., Lee C.C., Ling T.K., Ng E.K., Yu J., Huang T.H., To K.F., Chan M.W., Sung J.J.Y., Chan F.K.L. Helicobacter pylori causes epigenetic dysregulation of FOXD3 to promote gastric carcinogenesis. Gastroenterology 2013, 144:122-133.
61. Lu X.-X., Yu J.-L., Ying L.-S., Han J., Wang S., Yu Q.-M., Wang X.-B., Fang X.-H., Ling Z.-Q. Stepwise cumulation of RUNX3 methylation mediated by Helicobacter pylori infection contributes to gastric carcinoma progression. Cancer 2012, 118:5507-5517.
62. Loh J.T., Friedman D.B., Piazuelo M.B., Bravo L.E., Wilson K.T., Peek R.M., Correa P., Cover T.L. Analysis of Helicobacter pylori cagA promoter elements required for salt-induced upregulation of CagA expression. Infect. Immun. 2012, 80:3094-3106.
63. Link A., Kupcinskas J., Wex T., Malfertheiner P. Macro-role of MicroRNA in gastric cancer. Dig. Dis. 2012, 30:255-267.
64. Isomoto H., Matsushima K., Inoue N., Hayashi T., Nakayama T., Kunizaki M., Hidaka S., Nakayama M., Hisatsune J., Nakashima M., Nagayasu T., Nakao K., Hirayama T. Interweaving MicroRNAs and proinflammatory cytokines in gastric mucosa with reference to H. pylori infection. J. Clin. Immunol. 2012, 32:290-299.
65. Hayashi Y., Tsujii M., Wang J., Kondo J., Akasaka T., Jin Y., Li W., Nakamura T., Nishida T., Iijima H., Tsuji S., Kawano S., Hayashi N., Takehara T. CagA mediates epigenetic regulation to attenuate let-7 expression in Helicobacter pylori-related carcinogenesis. Gut 2012, (Epub ahead of print).
66. Niwa T., Tsukamoto T., Toyoda T., Mori A., Tanaka H., Maekita T., Ichinose M., Tatematsu M., Ushijima T. Inflammatory processes triggered by Helicobacter pylori infection cause aberrant DNA methylation in gastric epithelial cells. Cancer Res. 2010, 70:1430-1440.
67. Hur K., Niwa T., Toyoda T., Tsukamoto T., Tatematsu M., Yang H.K., Ushijima T. Insufficient role of cell proliferation in aberrant DNA methylation induction and involvement of specific types of inflammation. Carcinogenesis 2011, 32:35-41.
68. Wang F., Wang B., Qiao L. Association between obesity and gallbladder cancer. Front Biosci. 2012, 17:2550-2558.
69. Shen C., Zhao C.Y., Zhang R., Qiao L. Obesity-related hepatocellular carcinoma: roles of risk factors altered in obesity. Front. Biosci. 2012, 17:2356-2370.
70. Li Q., Zhang J., Zhou Y., Qiao L. Obesity and gastric cancer. Front. Biosci. 2012, 17:2383-2390.
71. Albaker W.I. Helicobacter pylori infection and its relationship to metabolic syndrome: is it a myth or fact?. Saudi J. Gastroenterol. 2011, 17:165-169.
72. Marie M.A. Seroprevalence of Helicobacter pylori infection in large series of patients in an urban area of Saudi Arabia. Korean J. Gastroenterol. 2008, 52:226-229.
73. Demir M., Gokturk H.S., Ozturk N.A., Kulaksizoglu M., Serin E., Yilmaz U. Helicobacter pylori prevalence in diabetes mellitus patients with dyspeptic symptoms and its relationship to glycemic control and late complications. Dig. Dis. Sci. 2008, 53:2646-2649.
74. Ikeda F., Doi Y., Yonemoto K., Ninomiya T., Kubo M., Shikata K., Hata J., Tanizaki Y., Matsumoto T., Iida M., Kiyohara Y. Hyperglycemia increases risk of gastric cancer posed by Helicobacter pylori infection: a population-based cohort study. Gastroenterology 2009, 136:1234-1241.
75. Gaddy J.A., Radin J.N., Loh J.T., Zhang F., Washington M.K., Peek R.M., Algood H.M.S., Cover T.L. High dietary salt intake exacerbates Helicobacter pylori-induced gastric carcinogenesis. Infect. Immun. 2013, 81:2258-2267.